FDA recognizes combination products as therapeutic or diagnostic products where the mechanism of action is based on a combination of drugs, devices, and/or biologics. Advancements through the development of combination products are important and challenging, offering the potential to bring new and exciting treatment options to patients.
We have extensive knowledge of and experience in product design, pre-clinical testing, clinical evaluations, and regulatory submissions for companies working to get their combination medical products developed and approved for commercialization.
OUR COMMITMENT
We are committed to consistently performing services with high quality, that deliver exceptional results, and add value to the client’s business.
For client surveys sent in the last two quarters, we received ratings of 4.98/5 points (9).